ShockWave Medical, Inc. (NASDAQ:SWAV)’s traded shares stood at 475,012 during the last session, with the company’s beta value hitting 0. At the close of trading, the stock’s price was $131.97, to imply an increase of 7.13% or $8.78 in intraday trading. The SWAV share’s 52-week high remains $143.79, putting it -8.96% down since that peak but still an impressive +83.32% since price per share fell to its 52-week low of $22.01. The company has a valuation of $4.52 Billion, with an average of 362.03 Million shares in intraday trading volume over the past 10 days and average of 413.61 Million shares over the past 3 months.
Analysts have given a consensus recommendation of Overweight for ShockWave Medical, Inc. (SWAV), translating to a mean rating of 2.5. Of 6 analyst(s) looking at the stock, none analyst(s) give SWAV a Sell rating. None of those analysts rate the stock as Overweight while 4 advise Hold as 2 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.47.
ShockWave Medical, Inc. (NASDAQ:SWAV) trade information
After registering a 7.13% upside in the last session, ShockWave Medical, Inc. (SWAV) has traded green over the past five days. The stock hit a weekly high of $140.0 this Tuesday, Feb 16, jumping 5.74% in its intraday price action. The 5-day price performance for the stock is 1.04%, and -7.1% over 30 days. With these gigs, the year-to-date price performance is 27.24%. Short interest in ShockWave Medical, Inc. (NASDAQ:SWAV) saw shorts transact 2.25 Million shares and set a 0.01 days time to cover.
Analysts on Wall Street suggest a consensus price target of $139.2, implying an increase of 5.48% to the stock’s current value. The extremes give us $130 and $151 for target low and target high price respectively. As such, SWAV has been trading 14.42% off suggested target high and -1.49% from its likely low.
ShockWave Medical, Inc. (SWAV) estimates and forecasts
Looking at statistics comparing ShockWave Medical, Inc. share performance against respective industry, we note that the company has underperformed competitors. ShockWave Medical, Inc. (SWAV) shares are +131.85% up over the last 6 months, with its year-to-date growth rate lower than industry average at -44.72% against 20.6%. But the analysts are intensifying their growth estimates for the 2021 fiscal year. Revenue is forecast to grow 20.3% this quarter before jumping 21.4% for the next one. The rating firms project that company’s revenue will grow 87.3% compared to the previous financial year.
An assessment of the company’s 5-year growth patterns shows that annual earnings fell an estimated 0% for the past 5-year period. While 2021 is set for a -40% return in earnings, projections for the next 5 years are at 77.7% annually.
ShockWave Medical, Inc. (NASDAQ:SWAV)’s Major holders
ShockWave Medical, Inc. insiders hold 6.33% of total outstanding shares, with institutional holders owning 99.75% of the shares at 106.49% float percentage. In total, 250 institutions holds shares in the company, led by FMR, LLC. As of Dec 30, 2020, the company held over 5.14 Million shares (or 15% of shares), all amounting to roughly $533.01 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The next major institution holding the largest number of shares is Blackrock Inc. with 2.4 Million shares, or about 7% of shares outstanding. As of the market price on Dec 30, 2020, these shares were worth $248.69 Million.